Altimmune, Inc. (ALT) — Institutional Holders, Q2 2026 (page 3)

211 institutional investment managers reported a ALT position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $456.2M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 201 to 211. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

ALT 13F holders ranked 201–211 of 211

Institutional investors reporting a position in Altimmune, Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
RMG Wealth Management#201 · 225 sh$659.00New
True Wealth Design#202 · 196 sh$596.00New
Bare Financial Services#203 · 196 sh$596.00New
GAMMA Investing#204 · 134 sh$407.00New
HARBOUR INVESTMENTS#205 · 100 sh$304.000.0%
Parallel Advisors#206 · 40 sh$122.000.0%
Bernard Wealth Management#207 · 15 sh$46.000.0%
FIRST HORIZON NATIONAL#208 · 3 sh$9.000.0%
HUNTINGTON NATIONAL BANK#209 · 2 sh$6.000.0%
Commonwealth Retirement Investments#210 · 1 sh$3.00New
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#211 · 2,737 sh—-61.6%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.